206 related articles for article (PubMed ID: 31138374)
1. Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion.
Curti C; Souab HK; Lamy E; Mathias F; Bornet C; Guinard B; Fersing C; Primas N; Albanèse J; Vanelle P
Pharmazie; 2019 Jun; 74(6):357-362. PubMed ID: 31138374
[TBL] [Abstract][Full Text] [Related]
2. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
4. Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
Viaene E; Chanteux H; Servais H; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2002 Aug; 46(8):2327-32. PubMed ID: 12121900
[TBL] [Abstract][Full Text] [Related]
5. Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.
Prescott WA; Gentile AE; Nagel JL; Pettit RS
P T; 2011 Nov; 36(11):723-63. PubMed ID: 22346306
[TBL] [Abstract][Full Text] [Related]
6. Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
Edwards SJ; Clarke MJ; Wordsworth S; Welton NJ
Curr Med Res Opin; 2009 Jan; 25(1):251-61. PubMed ID: 19210156
[TBL] [Abstract][Full Text] [Related]
7. Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
Mortensen JS; Jensen BP; Zhang M; Doogue M
Ther Drug Monit; 2019 Aug; 41(4):538-543. PubMed ID: 31306394
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941653
[TBL] [Abstract][Full Text] [Related]
9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
10. Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT.
Jang SM; Lewis SJ; Rhie SJ
J Crit Care; 2022 Dec; 72():154172. PubMed ID: 36270240
[TBL] [Abstract][Full Text] [Related]
11. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
[TBL] [Abstract][Full Text] [Related]
12. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients: A decision analytic model.
Tori K; Tansarli GS; Parente DM; Kalligeros M; Ziakas PD; Mylonakis E
Medicine (Baltimore); 2020 May; 99(20):e20022. PubMed ID: 32443305
[TBL] [Abstract][Full Text] [Related]
14. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
15. Drug-laboratory interaction between beta-lactam antibiotics and the galactomannan antigen test used to detect mould infections.
Otting KA; Stover KR; Cleary JD
Braz J Infect Dis; 2014; 18(5):544-7. PubMed ID: 24833197
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941654
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
Horita N; Shibata Y; Watanabe H; Namkoong H; Kaneko T
Clin Microbiol Infect; 2017 Oct; 23(10):723-729. PubMed ID: 28377312
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Kotapati S; Kuti JL; Nicolau DP
Surg Infect (Larchmt); 2005; 6(3):297-304. PubMed ID: 16201939
[TBL] [Abstract][Full Text] [Related]
19. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
Yost RJ; Cappelletty DM;
Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
[TBL] [Abstract][Full Text] [Related]
20. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
